abnormal neuroanatomy (with fra3)
abnormal neuroanatomy | embryonic stage (with fra3)
abnormal neuroanatomy | embryonic stage (with fra6)
axon | embryonic stage (with fra3)
axon | embryonic stage (with fra6)
Bolwig nerve (with fra3)
commissure & embryo & axon
commissure | embryonic stage (with fra3)
dMP2 neuron (with fra3)
dMP2 neuron (with fra3), with Scer\GAL4605, fraΔC.UAS.Tag:MYC
fascicle | embryonic stage (with fra3)
larval EW neuron (with fra6)
larval EW neuron | embryonic stage (with fra3)
larval posterior commissure (with fra3)
motor neuron (with fra3)
In 33 out of 72 abdominal segments examined in fra3/fra4 third instar larvae, the LCh1 cap cell migrates ventrally instead of dorsally; in 14 of 33 segments the cap cell travels along the ventral midline (along the VChA and VChB organs) and morphology of cap cells is largely normal, while in the remaining 19 segments the LCh1 cap cell often migrates towards the LCh5 LA cell and then turns ventrally after contact with the LA cell and cap cell morphology is abnormal. Similar phenotypes are seen with the migrating VChB cap cell, where in 18 out of 72 mutant segments it does not reach or attach to the LA cell.
Levels of apoptosis are not increased in the thoracic and abdominal segments of the fra4 mutant ventral nerve cord.
fra3/fra4 embryos display display commissure loss. One of the predominant defects in fra3/fra4 mutants is thinning and missing posterior commissures, with nearly a quarter of segments showing this defect.
Fas2-positive fascicles tend to fuse together or form small gaps in fra3/fra4 embryos.
Defects characterised by Fas2-positive axons ectopically exiting the central nervous system (CNS) are not observed in fra3/fra4 mutant embryos.
In fra3/fra4 mutant embryos, dendritic targeting to the midline is abolished in MN-VO4-6 and MN-VO4/5 projecting neurons.
In fra3/fra4 mutant embryos, 63% of MN-LL1 dendritic arbors lack the normally pronounced intermediate dendritic arborisation, while targeting of MN-DA3 dendrites is not significantly affected. MN-LL1 has a clearly reduced innervation of the intermediate neuropile in 63-64% of cases.
26% of fra3/fra4 embryos show defects in axon guidance in the Bolwig's nerve.
fra3/fra4 embryos show defects in the commissures of the central nervous system; 2% of anterior commissures are absent, 4% of anterior commissures are thin, 3% of posterior commissures are absent and 8% of posterior commissures are thin. 8% of segments fail to separate the anterior and posterior commissures correctly.
Heterozygous fra4 stage 16 embryos do not display abnormal midline crossing axon tract projections.
13% of segments have thin/missing commissures and 8% of segment have commissures with pathfinding errors in fra4/Df(2R)vg135 embryos. Breaks in the longitudinal connectives are seen in 10% of these embryos 23% of segments have thin/missing commissures and 13% of segment have commissures with pathfinding errors in fra4/fra4 embryos.
fra3/fra4 transheterozygote embryos show salivary gland guidance defects. Most mutants have salivary glands that lie parallel to the CNS midline as in wild type. However, in 4% of mutants, the glands curve laterally away from the midline and in 2% of mutants, the glands curve medially toward the midline.
dMP2 axons make pathfinding errors in fra3/fra4 mutant embryos, often extending laterally, turning anteriorly or stalling. Expression of fraΔC.Scer\UAS.T:Hsap\MYC under the control of Scer\GAL4605 in fra3/fra4 embryos results in abnormal spreading of the dMP2 growth cone over the region of induced ectopic NetB accumulation.
fra4 mutant clones in the eye show no discernable projection defects. fra4 mutant clones in the developing lamina are innervated abnormally. Wild type retinal fibers are incapable of innervating lamina target regions that lack fra function. Retinal fibers consistently avoid fra mutant patches and reroute to fra+ areas. Rerouting can occur in both the a-p and d-v axis. Incoming retinal fibers respect clonal boundaries.
The RP3 axon extends dorsally past and just adjacent to muscles 7 and 6 and then reached back to innervate them. RP3 neuron may extend into its normal muscle domain but fail to innervate muscles 7 and 6. The ISNb fails to innervate muscles 7 and 6. Scer\GAL4how-24B-mediated expression of NetAScer\UAS.cHa or NetBScer\UAS.cHa allows the axons of the transverse nerve to ectopically innervate muscles 7 and 6, loss of fra function suppresses this phenotype.
In fra3/fra4 embryos 12% of anterior commissures and 43% of posterior commissures in abdominal segments A1-A7 are thin or absent. Commissures that appear to have normal thickness are often less well organised than normal. Occasional breaks are also observed in the longitudinal tracts. A subset of motor axons exit the ventral CNS in the intersegmental nerve and extend dorsally, in fra3/fra4 embryos the axons often extend a colateral branch into an adjacent segment or make inappropriate contacts with dorsal muscles when they reach the dorsal muscle region.
fra6/fra4 has abnormal neuroanatomy | embryonic stage phenotype, enhanceable by Cyfip85.1/Cyfip85.1
fra6/fra4 has abnormal neuroanatomy | embryonic stage phenotype, enhanceable by Tace19
fra6/fra4 has abnormal neuroanatomy | embryonic stage phenotype, enhanceable by Scer\GAL4eg-Mz360/Tace10xUAS.Tag:HA
fra3/fra4 has abnormal neuroanatomy phenotype, enhanceable by robo2X123/robo2x135
fra3/fra4 has abnormal neuroanatomy | embryonic stage phenotype, enhanceable by Scer\GAL4insc-Mz1407/AblUAS.cHa
fra3/fra4 has abnormal neuroanatomy | embryonic stage phenotype, enhanceable by Scer\GAL4insc-Mz1407/AblKN.UAS
fra3/fra4 has abnormal neuroanatomy | embryonic stage phenotype, enhanceable by Scer\GAL4insc-Mz1407/Abl::Hsap\ABL1::Hsap\BCRP210.UAS
fra6/fra4 has abnormal neuroanatomy | embryonic stage phenotype, enhanceable by comm[+]/commΔe39
Df(2R)vg135/fra4 has abnormal neuroanatomy phenotype, enhanceable by Df(3L)Fpa1/+
Df(2R)vg135/fra4 has abnormal neuroanatomy phenotype, enhanceable by trio[+]/trioIMP159.4
Df(2R)vg135/fra4 has abnormal neuroanatomy phenotype, enhanceable by trioM89/trioIMP159.4
Df(2R)vg135/fra4 has abnormal neuroanatomy phenotype, enhanceable by trio[+]/trioM89
fra4 has abnormal neuroanatomy phenotype, enhanceable by Abl1/Abl[+]
fra4 has abnormal neuroanatomy phenotype, enhanceable by Abl4/Abl1
fra4 has abnormal neuroanatomy phenotype, enhanceable by Df(3L)Fpa1/+
fra4 has abnormal neuroanatomy phenotype, enhanceable by trio[+]/trioIMP159.4
fra4 has abnormal neuroanatomy phenotype, enhanceable by trioM89/trioIMP159.4
fra4 has abnormal neuroanatomy phenotype, enhanceable by trio[+]/trioM89
Df(2R)vg135/fra4 has abnormal neuroanatomy phenotype, enhanceable by Abl1/Abl[+]
fra4 has abnormal neuroanatomy phenotype, enhanceable by trioM89/trioS036810
fra4 has abnormal neuroanatomy phenotype, enhanceable by trio[+]/trioS036810
fra4 has abnormal neuroanatomy phenotype, enhanceable by Abl4/Abl[+]
Df(2R)vg135/fra4 has abnormal neuroanatomy phenotype, enhanceable by Abl4/Abl[+]
Df(2R)vg135/fra4 has abnormal neuroanatomy phenotype, enhanceable by Abl4/Abl1
fra3/fra4 has abnormal neuroanatomy | embryonic stage phenotype, non-enhanceable by Tace19
fra3/fra4 has abnormal neuroanatomy | embryonic stage phenotype, non-enhanceable by Scer\GAL4eg-Mz360/Tace10xUAS.Tag:HA
Dscam105518, fra4 has abnormal neuroanatomy phenotype, non-enhanceable by Dscam3c02826/Dscam3c02826
Dscam105518, fra4 has abnormal neuroanatomy | embryonic stage phenotype, suppressible by Scer\GAL4scrt-11-6/Dscam17.27.25.1.UAS.cZa
Dscam105518, fra4 has abnormal neuroanatomy | embryonic stage phenotype, suppressible by Scer\GAL4scrt-11-6/Dscam1UAS.1.30.30.2
Df(2R)vg135/fra4 has abnormal neuroanatomy phenotype, suppressible | partially by ena[+]/enaGC10
fra3/fra4 has abnormal neuroanatomy phenotype, suppressible by fra::unc-5fra.CD.UAS/Scer\GAL4elav.PLu
fra3/fra4 has abnormal neuroanatomy | embryonic stage phenotype, non-suppressible by Tace19
fra3/fra4 has abnormal neuroanatomy phenotype, non-suppressible by Scer\GAL4eg-Mz360/Rnor\DccUAS.Tag:MYC
fra3/fra4 has abnormal neuroanatomy | embryonic stage phenotype, non-suppressible by fra::robo1UAS.FΔC.Tag:MYC/Scer\GAL4elav.PLu
fra3/fra4 has abnormal neuroanatomy phenotype, non-suppressible by Scer\GAL4elav-C155/GαqQ203L.UAS
fra4/fra[+] is an enhancer of abnormal neuroanatomy | recessive phenotype of Nl1N-ts1
fra3, fra4, fraUAS.cKa, Scer\GAL4insc-Mz1407 is a non-enhancer of abnormal neuroanatomy | embryonic stage phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fraΔP1.UAS, fra3, fra4, Scer\GAL4insc-Mz1407 is a non-enhancer of abnormal neuroanatomy | embryonic stage phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra3, fra4, fraΔP2.UAS, Scer\GAL4insc-Mz1407 is a non-enhancer of abnormal neuroanatomy | embryonic stage phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra4/fra[+] is a non-enhancer of abnormal neuroanatomy phenotype of trioM89/trioIMP159.4
fra4/fra[+] is a non-enhancer of abnormal neuroanatomy phenotype of Df(3L)Fpa1/trioIMP159.4
fra3/fra4 is a suppressor of abnormal neuroanatomy | somatic clone | third instar larval stage phenotype of Scer\GAL4ppk.PG, Trim9UAS.Tag:HA
fraΔP3.UAS, fra3, fra4, Scer\GAL4insc-Mz1407 is a suppressor | partially of abnormal neuroanatomy | embryonic stage phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra3/fra4 is a suppressor of abnormal neuroanatomy | embryonic stage phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra4/fra[+] is a suppressor of visible phenotype of DysRNAi.NH2.UAS, Scer\GAL4Act.PU
fra4/fra[+] is a suppressor of visible phenotype of DysRNAi.C.UAS, Scer\GAL4Tub.PU
fra4/fra[+] is a suppressor | partially of abnormal neuroanatomy | embryonic stage 16 phenotype of Rac1V12.UAS, Scer\GAL4ftz.ng
fra4/fra[+] is a suppressor | partially of abnormal neuroanatomy | embryonic stage 16 phenotype of Cdc42V12.UAS, Scer\GAL4ftz.ng
fra4/fra[+] is a suppressor | partially of abnormal neuroanatomy phenotype of Ggal\MLCKct.UAS, Scer\GAL4ftz.ng
fra3/fra4 is a suppressor of abnormal neuroanatomy phenotype of GαqQ203L.UAS, Scer\GAL4elav-C155
fra3/fra4 is a suppressor | partially of abnormal neuroanatomy phenotype of Scer\GAL4ap-md544, unc-5UAS.Tag:HA,Tag:SS(wg)
fra3, fra4, fraUAS.cKa, Scer\GAL4insc-Mz1407 is a non-suppressor of abnormal neuroanatomy | embryonic stage phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fraΔP1.UAS, fra3, fra4, Scer\GAL4insc-Mz1407 is a non-suppressor of abnormal neuroanatomy | embryonic stage phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra3, fra4, fraΔP2.UAS, Scer\GAL4insc-Mz1407 is a non-suppressor of abnormal neuroanatomy | embryonic stage phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra3/fra4 is a non-suppressor of abnormal neuroanatomy phenotype of Scer\GAL4elav.PLu, unc-5UAS.Tag:HA,Tag:SS(wg)
Scer\GAL4ap-md544, fra3, fra4, fraUAS.cKa is a non-suppressor of abnormal neuroanatomy phenotype of Scer\GAL4ap-md544, unc-5UAS.Tag:HA,Tag:SS(wg)
Cyfip85.1, fra3/fra4 has abnormal neuroanatomy | embryonic stage phenotype
Cyfip85.1, fra3/fra4 has lethal - all die during embryonic stage phenotype
Dscam105518, fra4 has abnormal neuroanatomy | embryonic stage phenotype
AblUAS.cHa, Scer\GAL4insc-Mz1407, fra3/fra4 has abnormal neuroanatomy | embryonic stage phenotype
AblKN.UAS, Scer\GAL4insc-Mz1407, fra3/fra4 has abnormal neuroanatomy | embryonic stage phenotype
Df(1)NP5/+, fra4 has abnormal neuroanatomy | dominant phenotype
Dscam105518/Dscam[+], fra4 has abnormal neuroanatomy | dominant phenotype
Df(2R)en-SFX31, fra4 has abnormal neuroanatomy phenotype
fra6/fra4 has larval EW neuron | embryonic stage phenotype, enhanceable by Cyfip85.1/Cyfip85.1
fra6/fra4 has commissure | embryonic stage phenotype, enhanceable by Cyfip85.1/Cyfip85.1
fra6/fra4 has connective | embryonic stage phenotype, enhanceable by Cyfip85.1/Cyfip85.1
fra6/fra4 has axon | embryonic stage phenotype, enhanceable by Tace19
fra6/fra4 has larval EW neuron | embryonic stage phenotype, enhanceable by Tace19
fra6/fra4 has commissure | embryonic stage phenotype, enhanceable by Tace19
fra6/fra4 has axon | embryonic stage phenotype, enhanceable by Scer\GAL4eg-Mz360/Tace10xUAS.Tag:HA
fra6/fra4 has larval EW neuron | embryonic stage phenotype, enhanceable by Scer\GAL4eg-Mz360/Tace10xUAS.Tag:HA
fra3/fra4 has symmetrical commissure phenotype, enhanceable by robo2X123/robo2x135
fra3/fra4 has larval EW neuron phenotype, enhanceable by robo2X123/robo2x135
fra3/fra4 has larval ventral nerve cord commissure phenotype, enhanceable by Scer\GAL4insc-Mz1407/AblUAS.cHa
fra3/fra4 has larval ventral nerve cord commissure phenotype, enhanceable by Scer\GAL4insc-Mz1407/AblKN.UAS
fra3/fra4 has larval ventral nerve cord commissure phenotype, enhanceable by Scer\GAL4insc-Mz1407/Abl::Hsap\ABL1::Hsap\BCRP210.UAS
fra6/fra4 has larval EW neuron phenotype, enhanceable by comm[+]/commΔe39
Df(2R)vg135/fra4 has symmetrical commissure phenotype, enhanceable by Df(3L)Fpa1/+
Df(2R)vg135/fra4 has symmetrical commissure phenotype, enhanceable by trio[+]/trioIMP159.4
Df(2R)vg135/fra4 has symmetrical commissure phenotype, enhanceable by trioM89/trioIMP159.4
Df(2R)vg135/fra4 has symmetrical commissure phenotype, enhanceable by trio[+]/trioM89
fra4 has symmetrical commissure phenotype, enhanceable by Abl1/Abl[+]
fra4 has symmetrical commissure phenotype, enhanceable by Abl4/Abl1
fra4 has symmetrical commissure phenotype, enhanceable by Df(3L)Fpa1/+
fra4 has symmetrical commissure phenotype, enhanceable by trio[+]/trioIMP159.4
fra4 has symmetrical commissure phenotype, enhanceable by trioM89/trioIMP159.4
fra4 has symmetrical commissure phenotype, enhanceable by trio[+]/trioM89
fra4 has symmetrical commissure phenotype, enhanceable by trioM89/trioS036810
fra4 has symmetrical commissure phenotype, enhanceable by trio[+]/trioS036810
fra4 has symmetrical commissure phenotype, enhanceable by Abl4/Abl[+]
Df(2R)vg135/fra4 has symmetrical commissure phenotype, enhanceable by Abl1/Abl[+]
Df(2R)vg135/fra4 has symmetrical commissure phenotype, enhanceable by Abl4/Abl[+]
Df(2R)vg135/fra4 has symmetrical commissure phenotype, enhanceable by Abl4/Abl1
fra3/fra4 has presumptive embryonic salivary gland phenotype, enhanceable by mewM6
fra3/fra4 has axon | embryonic stage phenotype, non-enhanceable by Tace19
fra3/fra4 has larval EW neuron | embryonic stage phenotype, non-enhanceable by Tace19
fra3/fra4 has axon | embryonic stage phenotype, non-enhanceable by Scer\GAL4eg-Mz360/Tace10xUAS.Tag:HA
fra3/fra4 has larval EW neuron | embryonic stage phenotype, non-enhanceable by Scer\GAL4eg-Mz360/Tace10xUAS.Tag:HA
Dscam105518, fra4 has Bolwig nerve phenotype, non-enhanceable by Dscam3c02826/Dscam3c02826
Df(2R)vg135/fra4 has larval longitudinal connective phenotype, non-enhanceable by trioM89/trioIMP159.4
Df(2R)vg135/fra4 has larval longitudinal connective phenotype, non-enhanceable by Abl4/Abl1
Dscam105518, fra4 has commissure | embryonic stage phenotype, suppressible by Scer\GAL4scrt-11-6/Dscam17.27.25.1.UAS.cZa
Dscam105518, fra4 has commissure | embryonic stage phenotype, suppressible by Scer\GAL4scrt-11-6/Dscam1UAS.1.30.30.2
fra3/fra4 has larval EW neuron phenotype, suppressible by Scer\GAL4eg-Mz360/Rnor\DccUAS.Tag:MYC
fra3/fra4 has larval posterior commissure phenotype, suppressible by Scer\GAL4eg-Mz360/Rnor\DccUAS.Tag:MYC
fra3/fra4 has larval longitudinal connective phenotype, suppressible by Scer\GAL4eg-Mz360/Rnor\DccUAS.Tag:MYC
Df(2R)vg135/fra4 has symmetrical commissure phenotype, suppressible | partially by ena[+]/enaGC10
fra3/fra4 has larval anterior commissure phenotype, suppressible by fra::unc-5fra.CD.UAS/Scer\GAL4elav.PLu
fra3/fra4 has larval longitudinal connective phenotype, suppressible by fra::unc-5fra.CD.UAS/Scer\GAL4elav.PLu
fra3/fra4 has larval posterior commissure phenotype, suppressible by fra::unc-5fra.CD.UAS/Scer\GAL4elav.PLu
fra3/fra4 has axon | embryonic stage phenotype, non-suppressible by Tace19
fra3/fra4 has larval EW neuron | embryonic stage phenotype, non-suppressible by Tace19
fra3/fra4 has symmetrical commissure | embryonic stage phenotype, non-suppressible by Scer\GAL4elav-C155/GαqQ203L.UAS
fra3/fra4 has fascicle | embryonic stage phenotype, non-suppressible by Scer\GAL4elav-C155/GαqQ203L.UAS
fra4/fra[+] is an enhancer of pioneer neuron phenotype of Nl1N-ts1
fra3/fra4 is an enhancer of symmetrical commissure | embryonic stage phenotype of GαqQ203L.UAS, Scer\GAL4elav-C155
fra3/fra4 is an enhancer of fascicle | embryonic stage phenotype of GαqQ203L.UAS, Scer\GAL4elav-C155
fra3, fra4, fraUAS.cKa, Scer\GAL4insc-Mz1407 is a non-enhancer of larval ventral nerve cord commissure phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fraΔP1.UAS, fra3, fra4, Scer\GAL4insc-Mz1407 is a non-enhancer of larval ventral nerve cord commissure phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra3, fra4, fraΔP2.UAS, Scer\GAL4insc-Mz1407 is a non-enhancer of larval ventral nerve cord commissure phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra4/fra[+] is a non-enhancer of symmetrical commissure phenotype of trioM89/trioIMP159.4
fra4/fra[+] is a non-enhancer of symmetrical commissure phenotype of Df(3L)Fpa1/trioIMP159.4
fra3/fra4 is a suppressor of abdominal anterior ventral multidendritic neuron vdaa phenotype of Scer\GAL4ppk.PG, Trim9UAS.Tag:HA
fraΔP3.UAS, fra3, fra4, Scer\GAL4insc-Mz1407 is a suppressor | partially of commissure | ectopic phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra3/fra4 is a suppressor of commissure | ectopic phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra4/fra[+] is a suppressor of posterior crossvein phenotype of DysRNAi.NH2.UAS, Scer\GAL4Act.PU
fra4/fra[+] is a suppressor of posterior crossvein phenotype of DysRNAi.C.UAS, Scer\GAL4Tub.PU
fra4/fra[+] is a suppressor | partially of commissure | embryonic stage 16 phenotype of Rac1V12.UAS, Scer\GAL4ftz.ng
fra4/fra[+] is a suppressor | partially of larval ventral nerve cord commissure | embryonic stage 16 phenotype of Rac1V12.UAS, Scer\GAL4ftz.ng
fra4/fra[+] is a suppressor | partially of commissure | embryonic stage 16 phenotype of Cdc42V12.UAS, Scer\GAL4ftz.ng
fra4/fra[+] is a suppressor | partially of larval ventral nerve cord commissure | embryonic stage 16 phenotype of Cdc42V12.UAS, Scer\GAL4ftz.ng
fra3/fra4 is a suppressor of presumptive embryonic salivary gland phenotype of sli2
fra4/fra[+] is a suppressor | partially of larval longitudinal connective phenotype of Ggal\MLCKct.UAS, Scer\GAL4ftz.ng
fra3/fra4 is a suppressor | partially of larval ventral nerve cord phenotype of Scer\GAL4ap-md544, unc-5UAS.Tag:HA,Tag:SS(wg)
fra4 is a suppressor of larval transverse nerve phenotype of NetAUAS.cHa, Scer\GAL4how-24B
fra4 is a suppressor of larval transverse nerve phenotype of NetBUAS.cHa, Scer\GAL4how-24B
fraΔP1.UAS, fra3, fra4, Scer\GAL4insc-Mz1407 is a non-suppressor of commissure | ectopic phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra3, fra4, fraΔP2.UAS, Scer\GAL4insc-Mz1407 is a non-suppressor of commissure | ectopic phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra3, fra4, fraUAS.cKa, Scer\GAL4insc-Mz1407 is a non-suppressor of commissure | ectopic phenotype of Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407
fra3/fra4 is a non-suppressor of larval anterior commissure phenotype of Scer\GAL4elav.PLu, unc-5UAS.Tag:HA,Tag:SS(wg)
fra3/fra4 is a non-suppressor of larval posterior commissure phenotype of Scer\GAL4elav.PLu, unc-5UAS.Tag:HA,Tag:SS(wg)
fra3, fra4, fraUAS.cKa is a non-suppressor of larval ventral nerve cord phenotype of Scer\GAL4ap-md544, unc-5UAS.Tag:HA,Tag:SS(wg)
Dscam105518, fra4 has commissure | embryonic stage phenotype
Dscam105518, fra4 has embryonic/larval frontal nerve | embryonic stage | absent phenotype
Dscam105518, fra4 has frontal ganglion | embryonic stage phenotype
AblUAS.cHa, Scer\GAL4insc-Mz1407, fra3/fra4 has tract | ectopic | embryonic stage phenotype
AblKN.UAS, Scer\GAL4insc-Mz1407, fra3/fra4 has tract | ectopic | embryonic stage phenotype
Abl::Hsap\ABL1::Hsap\BCRP210.UAS, Scer\GAL4insc-Mz1407, fra3/fra4 has tract | ectopic | embryonic stage phenotype
Df(1)NP5/+, fra4 has Bolwig nerve phenotype
Dscam105518/Dscam[+], fra4 has Bolwig nerve phenotype
DysE6, fra4/fra[+] has posterior crossvein phenotype
DysRNAi.C.UAS, fra4/fra[+] has wing vein | ectopic phenotype
Df(2R)en-SFX31, fra4 has larval ventral nerve cord phenotype
Df(2R)en-SFX31, fra4 has larval anterior commissure phenotype
Df(2R)en-SFX31, fra4 has larval posterior commissure phenotype
Df(2R)en-SFX31, fra4 has lateral tract phenotype
fra3/fra4, mewM6 has presumptive embryonic salivary gland phenotype
NetBUAS.cHa, Scer\GAL4605, fra3/fra4 has dMP2 neuron phenotype
Dscam05518 fra4 double mutants show a significant increase in apoptosis in the thoracic and abdominal segments of the ventral nerve cord compared to controls.
A fra4 mutant background suppresses the ectopic contralateral projections seen when Trim9Scer\UAS.T:Ivir\HA1 is expressed in v'ada neurons under the control of Scer\GAL4ppk.PG.
Over-expression of AblScer\UAS.cHa using Scer\GAL4insc-Mz1407 enhances the degree of thinning and missing posterior commissures in fra3/fra4 embryos, and many anterior commissures disappear. Large bundles of axons are observed ectopically exiting the central nervous system (CNS), often extending beyond the CNS/PNS boundary.
Pan-neural expression of AblKN.Scer\UAS under the control of Scer\GAL4insc-Mz1407 in fra3/fra4 embryos significantly increases the frequency of thin and missing posterior commissure defects.
Commissure formation is restored in fra3/fra4 mutants expressing both fraΔP1.Scer\UAS and AblScer\UAS.cHa under the control of Scer\GAL4insc-Mz1407.
Commissure formation is restored in fra3/fra4 mutants expressing both fraΔP2.Scer\UAS and AblScer\UAS.cHa under the control of Scer\GAL4insc-Mz1407.
Commissure formation is restored in fra3/fra4 mutants expressing both fraΔP3.Scer\UAS and AblScer\UAS.cHa under the control of Scer\GAL4insc-Mz1407.
Nearly a third of hemi-segments in fra3/fra4 embryos expressing Scer\GAL4insc-Mz1407>AblScer\UAS.cHa exhibit defects characterised by Fas2-positive axons ectopically exiting the central nervous system (CNS).
Less than 10% of fra3/fra4 embryos expressing Scer\GAL4insc-Mz1407>AblKN.Scer\UAS exhibit defects characterised by Fas2-positive axons ectopically exiting the central nervous system (CNS).
67% of Dscam05518/Dscam05518 fra4/fra4 embryos show defects in axon guidance in the Bolwig's nerve.
The penetrance of the axon guidance defect phenotype that is seen in the Bolwig's nerve of Dscam05518/Dscam05518 fra4/fra4 double mutant embryos is not increased by addition of Dscam3c02826/Dscam3c02826.
30% of Df(1)NP5/+ ; fra4/+ embryos show defects in axon guidance in the Bolwig's nerve.
22.5% of Dscam05518/+ ; fra4/+ embryos show defects in axon guidance in the Bolwig's nerve.
Dscam05518 fra4 embryos show defects in the commissures of the central nervous system; 9% of anterior commissures are absent, 24% of anterior commissures are thin, 5% of posterior commissures are absent and 39% of posterior commissures are thin. 51% of segments fail to separate the anterior and posterior commissures correctly.
fra3/fra4 Dscam3c02826 embryos show defects in the commissures of the central nervous system; 2% of anterior commissures are absent, 3% of anterior commissures are thin, 1% of posterior commissures are absent and 9% of posterior commissures are thin. 48% of segments fail to separate the anterior and posterior commissures correctly.
fra4 Abl4 embryos show defects in the commissures of the central nervous system; 14% of anterior commissures are absent, 24% of anterior commissures are thin, 16% of posterior commissures are absent and 24% of posterior commissures are thin. 19% of segments fail to separate the anterior and posterior commissures correctly.
Dscam05518 fra4 Dscam3c02826 embryos show defects in the commissures of the central nervous system; 39% of anterior commissures are absent, 51% of anterior commissures are thin, 36% of posterior commissures are absent and 55% of posterior commissures are thin. 5% of segments fail to separate the anterior and posterior commissures correctly.
Dscam05518 fra4 Abl4 embryos show defects in the commissures of the central nervous system; 98% of anterior commissures are absent, 2% of anterior commissures are thin and 100% of posterior commissures are absent.
One copy of fra4 weakly suppresses the detached posterior crossvein phenotype seen when DysdsRNA.NH2.Scer\UAS is expressed under the control of Scer\GAL4Act.PU.
One copy of fra4 moderately suppresses the detached posterior crossvein phenotype seen when DysdsRNA.C.Scer\UAS is expressed under the control of Scer\GAL4tub.PU but produces extra wing vein material.
One copy of fra4 weakly in a DysE6/+ background results in posterior crossvein defects.
Heterozygous fra4 partially suppresses the incorrect midline crossing phenotype of ventral nerve cord axons in embryos overexpressing Cdc42V12.Scer\UAS via Scer\GAL4ftz.ng.
Heterozygous fra4 partially suppresses the incorrect midline crossing phenotype of ventral nerve cord axons in embryos overexpressing Rac1V12.Scer\UAS via Scer\GAL4ftz.ng.
Expression of fra::roboScer\UAS.FΔC.T:Hsap\MYCunder the control of Scer\GAL4elav.PLu fails to rescue the fra3/fra4 axon guidance phenotypes.
Approximately 66% of fra4/Df(2R)en-SFX31 double mutants exhibit defects in axonal pathfinding. Stage 15 embryos display dramatic defects in ventral nerve cord architecture, with the posterior commissures missing or fused with the anterior commissures, and longitudinal tracts thinner. Nearly all the segments are affected in these embryos.
In mewM6/Y; fra3/fra4 double mutant embryos, the misguided salivary gland phenotype is modified, compared to that of each single mutant. Like fra3/fra4 mutants, the majority (75%) of misguided glands curve laterally, but levels of penetrance are high, similar to mewM6/Y single mutants. In sli2; fra3/fra4 double mutants, the penetrance of the salivary gland guidance defects is by 40% compared to sli2 single mutants.
A reduction in midline crossing is observed upon removal of two copies of the fra gene in Scer\GAL4elav-C155/Gα49BQ203L.Scer\UAS;fra3/fra4, from 48.10% of abdominal segments exhibiting midline crossover in Scer\GAL4elav-C155/Gα49BQ203L.Scer\UAS embryos to 5.3% in Scer\GAL4elav-C155/Gα49BQ203L.Scer\UAS;fra3/fra4 mutant embryos. Embryos of the genotype Scer\GAL4elav-C155/Gα49BQ203L.Scer\UAS and fra3/fra4 exhibit breaks in Con-positive commissural axons and longitudinal tracts, similar to Scer\GAL4elav-C155/Gα49BQ203L.Scer\UAS; fra3/fra4 embryos, indicating that Gα49B does not have an effect on the fra mutant phenotype.
Expression of NetBScer\UAS.cHa under the control of Scer\GAL4605 in fra3/fra4 embryos results in abnormal spreading of the dMP2 growth cone over the region of ectopic NetB expression.
Expression of Rnor\DccScer\UAS.T:Hsap\MYC under the control of Scer\GAL4eg-Mz360 rescues the midline crossing defects found in EW neurons in fra3/fra4 mutants.
Expression of Rnor\DccY1418F.Scer\UAS.T:Hsap\MYC under the control of Scer\GAL4eg-Mz360 rescues the midline crossing defects found in EW neurons in fra3/fra4 mutants.
Over-expression of Abl::Hsap\ABL1::Hsap\BCRP210.Scer\UAS using Scer\GAL4insc-Mz1407 enhances the degree of thinning and missing posterior commissures in fra3/fra4 embryos, and many anterior commissures disappear. Large bundles of axons are observed ectopically exiting the central nervous system (CNS), often extending beyond the CNS/PNS boundary. The anterior commissures, which are virtually unaffected in fra3/fra4 embryos, are thin or missing in 41% of segments.
Re-expression of fraScer\UAS.cKa in fra3/fra4 mutants reverts the phenotype back to that seen when Abl::Hsap\ABL1::Hsap\BCRP210.Scer\UAS is expressed alone under the control of Scer\GAL4insc-Mz1407 : fuzzy commissures.
Re-expression of fraScer\UAS.cKa in fra3/fra4 mutants reverts the phenotype back to that seen when AblScer\UAS.cHa is expressed alone under the control of Scer\GAL4insc-Mz1407 : normal anterior and posterior commissure formation.
In fra3/fra4 mutants expressing Scer\GAL4insc-Mz1407>Abl::Hsap\ABL1::Hsap\BCRP210.Scer\UAS, expression of fraΔP1.Scer\UAS is able tor revert the commissure loss seen in fra3/fra4 mutants. These mutants display fuzzy commissures.
In fra3/fra4 mutants expressing Scer\GAL4insc-Mz1407>Abl::Hsap\ABL1::Hsap\BCRP210.Scer\UAS, expression of fraΔP2.Scer\UAS is able tor revert the commissure loss seen in fra3/fra4 mutants. These mutants display fuzzy commissures.
In fra3/fra4 mutants expressing Scer\GAL4insc-Mz1407>Abl::Hsap\ABL1::Hsap\BCRP210.Scer\UAS, expression of fraΔP3.Scer\UAS restores commissure formation in fra3/fra4 mutants. The frequency of fuzzy commissures is also significantly reduced.
fra3/fra4 significantly reduces the frequency of ectopic axonal midline-crossovers resulting from the expression of Scer\GAL4insc-Mz1407>Abl::Hsap\ABL1::Hsap\BCRP210.Scer\UAS.
fra3/fra4 fails to reduce the frequency of ectopic axonal midline-crossovers resulting from the expression of Scer\GAL4insc-Mz1407>Abl::Hsap\ABL1::Hsap\BCRP210.Scer\UAS when fraScer\UAS.cKa is co-expressed.
fra3/fra4 fails to reduce the frequency of ectopic axonal midline-crossovers resulting from the expression of Scer\GAL4insc-Mz1407>Abl::Hsap\ABL1::Hsap\BCRP210.Scer\UAS when fraΔP1.Scer\UAS is co-expressed.
fra3/fra4 fails to reduce the frequency of ectopic axonal midline-crossovers resulting from the expression of Scer\GAL4insc-Mz1407>Abl::Hsap\ABL1::Hsap\BCRP210.Scer\UAS when fraΔP2.Scer\UAS is co-expressed.
fra3/fra4 significantly reduces the frequency of ectopic axonal midline-crossovers resulting from the expression of Scer\GAL4insc-Mz1407>Abl::Hsap\ABL1::Hsap\BCRP210.Scer\UAS when fraΔP3.Scer\UAS is co-expressed.
Nearly a third of hemi-segments in fra3/fra4 embryos expressing Scer\GAL4insc-Mz1407>Abl::Hsap\ABL1::Hsap\BCRP210.Scer\UAS exhibit defects characterised by Fas2-positive axons ectopically exiting the central nervous system (CNS).
The midline crossover phenotype caused expression of Ggal\MLCKct.Scer\UAS under the control of Scer\GAL4ftz.ng is partially suppressed by fra4/+.
fra3/fra4 is rescued by fraUAS.cOa.Tag:MYC/Scer\GAL4elav.PLu
fra3/fra4 is rescued by fra9YF.UAS.Tag:MYC/Scer\GAL4elav.PLu
fra3/fra4 is rescued by Scer\GAL4gcm.PU/fraUAS.cKa
fra3/fra4 is rescued by fraUAS.cKa/Scer\GAL4eve.CQ2
fra3/fra4 is rescued by Scer\GAL4eg-Mz360/fraUAS.Tag:MYC
fra3/fra4 is rescued by fraUAS.Tag:MYC/Scer\GAL4elav.PLu
fra3/fra4 is rescued by Scer\GAL4eg-Mz360/fraUAS.Tag:HA
fra3/fra4 is rescued by fraΔP1.UAS.Tag:MYC/Scer\GAL4eg-Mz360
fra3/fra4 is rescued by Scer\GAL4eg-Mz360/fraΔP2.UAS.Tag:MYC
fra3/fra4 is rescued by Scer\GAL4eg-Mz360/fraΔP1ΔP2.UAS.Tag:MYC
fra3/fra4 is rescued by fraUAS.cKa/Scer\GAL4elav.PLu
fra3/fra4 is rescued by Scer\GAL4605/fraUAS.cKa
fra3/fra4 is partially rescued by Scer\GAL4ppk.PG/fraUAS.cKa
fra3/fra4 is partially rescued by Scer\GAL4MZ1580/fraUAS.cKa
fra3/fra4 is partially rescued by Scer\GAL4insc-Mz1407/fraUAS.cKa
fra3/fra4 is not rescued by Scer\GAL4repo/fraUAS.cKa
fra3/fra4 is not rescued by Scer\GAL4pros.PMG/fraUAS.cKa
fra3/fra4 is not rescued by Scer\GAL4elav.PU/fraUAS.cKa
fra3/fra4 is not rescued by Scer\GAL4Mz605/fraUAS.cKa
fra3/fra4 is not rescued by Scer\GAL4eg-Mz360/fraΔP3.UAS.Tag:MYC
fra3/fra4 is not rescued by Scer\GAL4eg-Mz360/fraΔP3.5.UAS.Tag:MYC
fra3/fra4 is not rescued by Scer\GAL4eg-Mz360/fraUAS.Tag:Myr(Src64B),Tag:MYC
fra3/fra4 is not rescued by fraΔC.UAS.Tag:HA/Scer\GAL4elav.PLu
fra3/fra4 is not rescued by Scer\GAL415J2/fraUAS.cKa
fra3/fra4 is not rescued by Scer\GAL4how-24B/fraUAS.cKa
Expression of fraScer\UAS.cOa.T:Hsap\MYC in all neurons, through expression under the control of Scer\GAL4elav.PLu, rescues EW midline crossing defects in fra3/fra4 mutants.
Expression of fra9YF.Scer\UAS.T:Hsap\MYC in all neurons, through expression under the control of Scer\GAL4elav.PLu, rescues EW midline crossing defects in fra3/fra4 mutants.
Expression of fraScer\UAS.cKa in C4da neurons under the control of Scer\GAL4ppk.PG partially rescues the axonal defects seen in fra3/fra4 mutants.
Expression of fraScer\UAS.cKa under the control of Scer\GAL4gcm.PU rescues the defects in interface glial cell migration seen in fra3/fra4 embryos.
Expression of fraScer\UAS.cKa under the control of Scer\GAL4MZ1580 weakly rescues the defects in interface glial cell migration seen in fra3/fra4 embryos.
The defects in interface glial cell migration seen in fra3/fra4 embryos are not rescued by expression of fraScer\UAS.cKa under the control of any one of Scer\GAL4repo, Scer\GAL4pros.PMG, Scer\GAL4elav.PU or Scer\GAL4Mz605.
Expression of fraScer\UAS.cKa under the control of Scer\GAL4eve.CQ2 rescues dendritic targeting to the midline in fra3/fra4 mutant MN-VO4-6 and MN-VO4/5 neurons.
Expression of fraScer\UAS.cKa under the control of Scer\GAL4eve.CQ2 selectively in MN-LL1 neurons in fra3/fra4 mutant embryos efficiently rescues dendritic targeting to the intermediate neuropile. Moreover, this manipulation leads to a greater proportion of dendritic branches innervating the intermediate neuropile.
Expression of fraScer\UAS.T:Hsap\MYC under the control of Scer\GAL4eg-Mz360 cell-autonomously rescues the EW guidance defects of fra3/fra4 embryos.
Expression of fraScer\UAS.T:Ivir\HA under the control of Scer\GAL4eg-Mz360 cell-autonomously rescues the EW guidance defects of fra3/fra4 embryos.
Expression of fraScer\UAS.cKa under the control of Scer\GAL415J2 does not rescue the dMP2 axonal phenotype of fra3/fra4 embryos. Expression of fraScer\UAS.cKa under the control of Scer\GAL4605 does rescue the dMP2 axonal phenotype of fra3/fra4 embryos.
Scer\GAL41407 induced expression of fraScer\UAS.cKa in fra3/fra4 embryos rescues the commissure phenotype, commissures form normally in abdominal segments A1-A7. ISN motor axons also innervate their targets at near wild type levels.